Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study
Clinical trial NCT02780089 · COMPLETED
Trial details
- NCT number
- NCT02780089
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-10-23
- Primary completion
- 2020-09-08
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.